Report overview
This report contains market size and forecasts of Preclinical Drug Development Services in Global, including the following market information:
Global Preclinical Drug Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preclinical Drug Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
API Preparation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preclinical Drug Development Services include Wuxi AppTec, Labcorp, Charles River, Eurofins Scientific, PPD, Inc., ICON Plc., Pharmaron, Inotiv and ChemPartner, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preclinical Drug Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preclinical Drug Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preclinical Drug Development Services Market Segment Percentages, by Type, 2021 (%)
API Preparation
Formulation Studies
Safety Studies
ADME Stuies
Global Preclinical Drug Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preclinical Drug Development Services Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Bio-pharmaceutical
Global Preclinical Drug Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preclinical Drug Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preclinical Drug Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preclinical Drug Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wuxi AppTec
Labcorp
Charles River
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Noble Life Sciences
